Clinical Trial Update: Aerosol Liposomal Cyclosporine for Chronic Rejection in Lung Transplant Recipients [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial of aerosol liposomal cyclosporine for chronic rejection in lung transplant recipients has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchiolitis Obliterans
• Disorder Related to Lung Transplantation
• Rejection of Lung Transplant

Drugs mentioned

• aerosol liposomal cyclosporine (cyclosporine)

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Disorder Related to Lung Transplantation, Bronchiolitis Obliterans | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-10-25